These CD27-based T2-CAR T cells demonstrated a higher survival rate in the spleens and tumor tissues of tumor-bearing mice and exhibited upregulated IL-7Rα expression and downregulated PD-1 expression, indicating a multifaceted mechanism of enhanced killing effect. This evidence concerns the gene CD27 and neoplasm.